|
HSP90AB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.110980E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.064360E-01 |
| Normal-vs-Stage2 |
3.863600E-01 |
| Normal-vs-Stage3 |
2.260800E-03 |
| Normal-vs-Stage4 |
1.283580E-02 |
| Stage1-vs-Stage2 |
2.167800E-01 |
| Stage1-vs-Stage3 |
7.016200E-04 |
| Stage1-vs-Stage4 |
9.95499999999483E-05 |
| Stage2-vs-Stage3 |
1.161380E-01 |
| Stage2-vs-Stage4 |
2.955800E-01 |
| Stage3-vs-Stage4 |
4.639600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.890990E-01 |
| Normal-vs-AfricanAmerican |
3.021200E-01 |
| Normal-vs-Asian |
2.113200E-01 |
| Caucasian-vs-AfricanAmerican |
4.052200E-01 |
| Caucasian-vs-Asian |
2.646800E-01 |
| AfricanAmerican-vs-Asian |
6.964400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.312600E-01 |
| Normal-vs-Female |
5.141200E-03 |
| Male-vs-Female |
3.595600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.485000E-01 |
| Normal-vs-Extreme_Weight |
7.622000E-01 |
| Normal-vs-Obese |
4.555800E-02 |
| Normal-vs-Extreme_Obese |
7.594500E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.347400E-01 |
| Normal_Weight-vs-Obese |
1.147560E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.340430E-01 |
| Extreme_Weight-vs-Obese |
4.470300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.975600E-01 |
| Obese-vs-Extreme_Obese |
5.141400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.976470E-02 |
| Normal-vs-Age(41-60Yrs) |
3.404200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.558000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.830430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.565000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.522700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.841400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.005800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.700440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.470000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.878000E-01 |
| Normal-VS-Type2 PRCC |
8.397200E-03 |
| Normal-VS-KIRP CIMP |
9.099100E-03 |
| Normal-VS-Unclassified PRCC |
7.199200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.247190E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.384320E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.533600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.386400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.576300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.122480E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.601600E-01 |
| Normal-vs-N1 |
7.938200E-02 |
| Normal-vs-N2 |
1.075700E-03 |
| N0-vs-N1 |
9.532200E-02 |
| N0-vs-N2 |
4.352600E-01 |
| N1-vs-N2 |
1.663800E-01 |
|
|
